Association Between Severity of Diabetic Neuropathy and Success in Weight Loss During Hospitalization Among Japanese Patients with Type 2 Diabetes: A Retrospective Observational Study

References

• Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diab Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023
   PubMed Web of Science ®Google Scholar
• Nanditha A, Ma RC, Ramachandran A, et al. Diabetes in Asia and the pacific: implications for the global epidemic. Diab Care. 2016;39(3):472–485. doi:10.2337/dc15-1536
   PubMed Web of Science ®Google Scholar
• Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diab Care. 2011;34(6):1249–1257. doi:10.2337/dc11-0442
   PubMed Web of Science ®Google Scholar
• Lean ME, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DIRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10):541–551. doi:10.1016/S0140-6736(17)33102-1
   PubMedGoogle Scholar
• American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. Circulation. 2014;129(Suppl2):S102–S138. 10.1161/01.cir.0000437739.71477.ee.
   PubMedGoogle Scholar
• Muramoto A, Matsushita M, Kato A, et al. Three percent weight reduction is the minimum requirement to improve health hazards in obese and overweight people in Japan. Obes Res Clin Pract. 2014;8(5):e466–e475. doi:10.1016/j.orcp.2013.10.003
   PubMed Web of Science ®Google Scholar
• Asakawa A, Inui A, Yuzuriha H, et al. Characterization of the effects of pancreatic polypeptide in the regulation of energy balance. Gastroenterology. 2003;124(5):1325–1336. doi:10.1016/S0016-5085(03)00216-6
   PubMed Web of Science ®Google Scholar
• Koda S, Date Y, Murakami N, et al. The role of the vagal nerve in peripheral PYY3–36-induced feeding reduction in rats. Endocrinology. 2005;146(5):2369–2375. doi:10.1210/en.2004-1266
   PubMedGoogle Scholar
• Izumida Y, Yahagi N, Takeuchi Y, et al. Glycogen shortage during fasting triggers liver-brain-adipose neurocircuitry to facilitate fat utilization. Nat Commun. 2013;4:2316. doi:10.1038/ncomms3316
   PubMed Web of Science ®Google Scholar
• Cork SC. The role of the vagus nerve in appetite control: implications for the pathogenesis of obesity. J Neuroendocrinol. 2018;30(11):e12643. doi:10.1111/jne.12643
   PubMedGoogle Scholar
• Rothschild AH, Weinberg CR, Halter JB, Porte D, Pfeifer MA. Sensitivity of R-R variation and valsalva ratio in assessment of cardiovascular diabetic autonomic neuropathy. Diab Care. 1987;10(6):735–741. doi:10.2337/diacare.10.6.735
   PubMedGoogle Scholar
• Haneda M, Utsunomiya K, Koya D, et al. Classification of diabetic nephropathy 2014. J Japan Diab Soc. 2014;57(7):529–534.
   Google Scholar
• Davis MD. Vitreous contraction in proliferative diabetic retinopathy. Arch Ophthalmol. 1965;74(6):741–751. doi:10.1001/archopht.1965.00970040743003
   PubMedGoogle Scholar
• Yasuda H, Sanada M, Kitada K, et al. Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy. Diab Res Clin Pract. 2007;77(Suppl 1):S178–S183. doi:10.1016/j.diabres.2007.01.053
   PubMedGoogle Scholar
• The Japan Diabetes Society. Diet therapy. In: Practice Guideline for the Treatment for Diabetes in Japan. Nankodo:Tokyo, Japan. 2016. pp. 37–66. published in Japanese.
   Google Scholar
• Jin Y, Kanamori A, Ito S, et al. Cross-sectional survey of diabetic neuropathy in Kanagawa and clinical significance of a touch test using tissue paper. J Diab Investig. 2012;3(3):252–258. doi:10.1111/j.2040-1124.2011.00174.x
   PubMedGoogle Scholar
• Takahara M, Fujiwara Y, Sakamoto F, et al. Assessment of vibratory sensation with a tuning fork at different sites in Japanese patients with diabetes mellitus. J Diab Investig. 2014;5(1):90–93. doi:10.1111/jdi.12126
   PubMedGoogle Scholar
• Yamada T, Oka Y, Katagiri H. Inter-organ metabolic communication involved in energy homeostasis: potential therapeutic targets for obesity and metabolic syndrome. Pharmacol Ther. 2008;117(1):188–198. doi:10.1016/j.pharmthera.2007.09.006
   PubMed Web of Science ®Google Scholar
• Duca FA, Côté CD, Rasmussen BA, et al. Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats. Nat Med. 2015;21(5):506–511. doi:10.1038/nm.3787
   PubMed Web of Science ®Google Scholar
• Nishizawa M, Nakabayashi H, Uehara K, et al. Intraportal GLP-1 stimulates insulin secretion predominantly through the hepatoportal-pancreatic vagal reflex pathways. Am J Physiol Endocrinol Metab. 2013;305(3):E376–E387. doi:10.1152/ajpendo.00565.2012
   PubMed Web of Science ®Google Scholar
• Kanoski SE, Fortin SM, Arnold M, Grill HJ, Hayes MR. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4. Endocrinology. 2011;152(8):3103–3112. doi:10.1210/en.2011-0174
   PubMed Web of Science ®Google Scholar
• Sawada Y, Izumida Y, Takeuchi Y, et al. Effect of sodium-glucose cotransporter 2 (SGLT2) inhibition on weight loss is partly mediated by liver-brain-adipose neurocircuitry. Biochem Biophys Res Commun. 2017;493(1):40–45. doi:10.1016/j.bbrc.2017.09.081
   PubMedGoogle Scholar
• Yao G, Kang L, Li J, et al. Effective weight control via an implanted self-powered vagus nerve stimulation device. Nat Commun. 2018;9(1):5349. doi:10.1038/s41467-018-07764-z
   PubMedGoogle Scholar
• Ogawa K, Sasaki H, Yamasaki H, et al. Peripheral nerve functions may deteriorate parallel to the progression of microangiopathy in diabetic patients. Nutr Metab Cardiovasc Dis. 2006;16(5):313–321. doi:10.1016/j.numecd.2005.06.003
   PubMedGoogle Scholar